AratiSuvasDesaiMD

Oncology • Philadelphia, PA

Hematologic Oncology, Neuro-Oncology

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Desai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Desai's full profile

Already have an account?

Office
3400 Civic Center Blvd
Fl 23
Philadelphia, PA 19104
Phone+1 215-615-5858

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2006 - 2009
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Kentucky College of MedicineClass of 2001

Certifications & Licensure

CA State Medical License 2004 - Present
PA State Medical License 2009 - 2024
MD State Medical License 2006 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma Start of enrollment: 2012 May 31
Completed
Phase 1
Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Start of enrollment: 2013 Aug 19
Active, not recruiting
Phase 1
Terameprocol in Treating Patients With Recurrent High Grade Glioma Start of enrollment: 2018 May 03
Completed
Phase 1
Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas Start of enrollment: 2018 Oct 30
Terminated
Phase 1
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2017 Jun 07
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

Corticosteroid-dependent association between prognostic peripheral blood cell-free DNA levels and neutrophil-mediated NETosis in patients with glioblastoma.
Jacob E Till, Nicholas J Seewald, Zachariya Yazdani, Zhuoyang Wang, Dominique Ballinger
Clinical Cancer Research. 2025-01-31
Phase I study of adavosertib with radiation therapy and temozolomide in newly diagnosed glioblastoma and intratumoral drug levels in recurrent glioblastoma.
Eudocia Q Lee, Brian M Alexander, Carlos G Romo, Jeffrey G Supko, Nathalie Y R Agar
Clinical Cancer Research. 2025-01-17
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma.
Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak, Tony J Wang, Arati Desai
Clinical Cancer Research. 2025-01-17

Journal Articles

Three‐Dimensional Echo Planar Spectroscopic Imaging for Differentiation of True Progression from Pseudoprogression in Patients with Glioblastoma
Arati Desai, Ronald L Wolf, MacLean Nasrallah, Suyash Mohan, Steven Brem, NMR in Biomedicine

Press Mentions

Losing Mom to Brain Cancer Fuels Penn Medicine Expert’s Mission for BreakthroughJuly 20th, 2022
STELLAR Trial Introduces New Treatment Options for Anaplastic AstrocytomaJanuary 31st, 2020
Glioblastoma Multiforme Translational Center of ExcellenceMarch 1st, 2019